Want to see JP:2413 full AI Analyst Report?

M3 (2413) Price & Analysis

5 Followers

2413 Stock Chart & Stats

¥2157.00

¥5.00(0.35%)

At close: Jan 08 4:00 PM EST

¥2157.00

¥5.00(0.35%)

Day’s Range― - ―

52-Week Range¥1,297.00 - ¥2,746.00

Previous CloseN/A

Volume2.86M

Average Volume (3M)2.99M

Market Cap

¥1.20T

Enterprise Value¥951.20B

Total Cash (Recent Filing)¥102.14B

Total Debt (Recent Filing)¥26.14B

Price to Earnings (P/E)24.4

Beta0.74

Next Earnings

Jul 29, 2026

EPS Estimate

20.05

Next Dividend Ex-DateN/A

Dividend Yield1.01%

Share Statistics

EPS (TTM)60.49

Shares Outstanding679,124,300

10 Day Avg. Volume2,689,370

30 Day Avg. Volume2,988,500

Financial Highlights & Ratios

PEG Ratio1.02

Price to Book (P/B)2.66

Price to Sales (P/S)3.09

P/FCF Ratio17.37

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥2,180.00

Price Target Upside1.07% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

EPS Forecast (FY)81.71

Revenue Forecast (FY)¥392.57B

Bulls Say, Bears Say

Bulls Say

Robust Free Cash Flow GenerationHigh free cash flow that closely tracks earnings provides durable internal funding for R&D, platform investment, dividends or M&A. Consistent FCF reduces reliance on external financing and supports long-term strategic initiatives and capital allocation flexibility.

Conservative Balance Sheet With Low LeverageVery low leverage and growing equity give the company strong financial flexibility to fund growth or weather downturns. This durable strength limits refinancing risk, supports investment in product expansion, and preserves optionality for strategic transactions.

Re-accelerating Revenue And Solid ProfitabilityRenewed top-line momentum combined with strong gross and net margins indicates enduring demand for its healthcare platforms and services. These structural revenue and margin characteristics support sustainable cash generation and reinvestment into differentiated offerings.

Bears Say

Margin Compression Versus Prior YearsSustained margin compression suggests structural cost or mix headwinds that could erode profitability over time. If higher operating costs or a shift to lower-margin services persist, long-term reinvestment capacity and return on capital may be constrained.

Uneven Operating Cash Flow ConversionVolatile operating cash conversion indicates working-capital or timing variability that can reduce predictability of free cash flow. Persistent variability complicates capital planning and could limit reliable dividend, buyback, or acquisition funding over the medium term.

ROE Trended Down From Peak LevelsDeclining ROE from prior peaks may reflect slower margin expansion or capital intensity increases, signaling potential limits to shareholder return growth. If the trend persists, it could indicate the company is reaching maturity in core markets or facing competitive pressures.

M3 News

M3 Affirms Independence Despite Sony’s 34.5% Stake and Reports No Dealings in FY2025

M3 ( ($JP:2413) ) just unveiled an announcement. M3, Inc., a Tokyo-based digital healthcare and medical information services...

18d ago

M3 to Consolidate WISEMAN Through Share Acquisition

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. has announced the acquisition of shares...

25d ago

M3 to Acquire WISEMAN to Boost Healthcare and Nursing Care DX

M3 ( ($JP:2413) ) just unveiled an update. M3, Inc. has decided to acquire all outstanding shares of...

25d ago

M3 Reports No Share Buybacks So Far Under ¥20 Billion Repurchase Plan

M3 ( ($JP:2413) ) has provided an announcement. M3, Inc. reported that it did not repurchase any of...

29d ago

M3 Issues Investor Presentation With Caution on Projections

M3 ( ($JP:2413) ) just unveiled an announcement. M3, Inc. has released a presentation outlining forecasts, plans, management...

2M ago

M3 Launches Up to ¥20 Billion Share Buyback to Bolster Capital Efficiency

M3 ( ($JP:2413) ) has shared an update. M3, Inc. has approved a share repurchase program of up...

2M ago

M3 Lifts Profit 21% and Hikes Dividend as It Targets Further Growth in FY2027

M3 ( ($JP:2413) ) has provided an update. M3 reported strong results for the fiscal year ended March...

2M ago

Is MTHRF a Buy, Before Earnings?

M3 (MTHRF) is scheduled to report 4th quarter earnings on 05/01/2026, before the market opens. Regarding Q4 estimates,...

2M ago

M3 Completes ¥20 Billion Share Buyback, Tightening Free Float

The latest update is out from M3 ( ($JP:2413) ). M3, Inc. has completed a share repurchase program...

4M ago

M3 Advances Share Buyback, Acquires 5.8 Million Shares in February

M3 ( ($JP:2413) ) just unveiled an update. M3, Inc. reported progress on its ongoing share repurchase program...

4M ago

M3 Inc. downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded M3 Inc. (MTHRF) to Neutral from Buy with a 2,500 yen price target The firm...

9M ago

M3 Inc. initiated with a Buy at Goldman Sachs

Goldman Sachs analyst Akinori Ueda initiated coverage of M3 Inc. with a Buy rating and 5,450 yen price...

4y ago

MTHRF

2413 FAQ

What was M3 Inc’s price range in the past 12 months?

M3 Inc lowest stock price was ¥1297.00 and its highest was ¥2746.00 in the past 12 months.

What is M3 Inc’s market cap?

M3 Inc’s market cap is ¥1.20T.

When is M3 Inc’s upcoming earnings report date?

M3 Inc’s upcoming earnings report date is Jul 29, 2026 which is in 29 days.

How were M3 Inc’s earnings last quarter?

M3 Inc released its earnings results on May 01, 2026. The company reported ¥11.11 earnings per share for the quarter, missing the consensus estimate of ¥14.08 by -¥2.97.

Is M3 Inc overvalued?

According to Wall Street analysts M3 Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does M3 Inc pay dividends?

M3 Inc pays a Annually dividend of ¥22 which represents an annual dividend yield of 1.01%. See more information on M3 Inc dividends here

What is M3 Inc’s EPS estimate?

M3 Inc’s EPS estimate is 20.05.

How many shares outstanding does M3 Inc have?

M3 Inc has 679,124,300 shares outstanding.

What happened to M3 Inc’s price movement after its last earnings report?

M3 Inc reported an EPS of ¥11.11 in its last earnings report, missing expectations of ¥14.08. Following the earnings report the stock price went down -0.499%.

Which hedge fund is a major shareholder of M3 Inc?

Currently, no hedge funds are holding shares in JP:2413

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M3 Inc

M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.

M3 (2413) Earnings & Revenues

Historic Earnings Reports

2413 Stock 12 Month Forecast

Average Price Target

¥2,180.00

▲(1.07% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1473":"¥1,473","1930":"¥1,930","2387":"¥2,387","2844":"¥2,844","3301":"¥3,301"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.30K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2180,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.18K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1600,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥1.60K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1473,1930,2387,2844,3301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1474.5,1614.923076923077,1755.3461538461538,1895.769230769231,2036.1923076923076,2176.6153846153848,2317.038461538462,2457.4615384615386,2597.8846153846152,2738.3076923076924,2878.7307692307695,3019.153846153846,3159.5769230769233,{"y":3300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1474.5,1528.7692307692307,1583.0384615384614,1637.3076923076924,1691.576923076923,1745.8461538461538,1800.1153846153845,1854.3846153846152,1908.6538461538462,1962.923076923077,2017.1923076923076,2071.4615384615386,2125.730769230769,{"y":2180,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1474.5,1484.1538461538462,1493.8076923076924,1503.4615384615386,1513.1153846153845,1522.7692307692307,1532.423076923077,1542.076923076923,1551.7307692307693,1561.3846153846155,1571.0384615384614,1580.6923076923076,1590.3461538461538,{"y":1600,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1997.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1901.11,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1865.575,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2224.871,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2238.197,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2141.463,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2421.793,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2086.68,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1857.678,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1645.95,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1669,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1496.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1474.5,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >